US20190321546A1 - Electromagnetic signal-based infusion pump control - Google Patents

Electromagnetic signal-based infusion pump control Download PDF

Info

Publication number
US20190321546A1
US20190321546A1 US16/502,196 US201916502196A US2019321546A1 US 20190321546 A1 US20190321546 A1 US 20190321546A1 US 201916502196 A US201916502196 A US 201916502196A US 2019321546 A1 US2019321546 A1 US 2019321546A1
Authority
US
United States
Prior art keywords
user
infusion pump
pump
wearable infusion
input
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US16/502,196
Inventor
Michael Michaud
Justin Brown
Caleb Butler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tandem Diabetes Care Inc
Original Assignee
Tandem Diabetes Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tandem Diabetes Care Inc filed Critical Tandem Diabetes Care Inc
Priority to US16/502,196 priority Critical patent/US20190321546A1/en
Assigned to TANDEM DIABETES CARE, INC. reassignment TANDEM DIABETES CARE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BROWN, JUSTIN, MICHAUD, MICHAEL, BUTLER, CALEB
Publication of US20190321546A1 publication Critical patent/US20190321546A1/en
Assigned to BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT reassignment BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TANDEM DIABETES CARE, INC.
Assigned to TANDEM DIABETES CARE, INC. reassignment TANDEM DIABETES CARE, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3546Range
    • A61M2205/3569Range sublocal, e.g. between console and disposable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3576Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502User interfaces, e.g. screens or keyboards
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502User interfaces, e.g. screens or keyboards
    • A61M2205/505Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/58Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/587Lighting arrangements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8206Internal energy supply devices battery-operated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8237Charging means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8237Charging means
    • A61M2205/8243Charging means by induction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00Ancillary equipment
    • A61M2209/01Remote controllers for specific apparatus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/20Blood composition characteristics
    • A61M2230/201Glucose concentration

Definitions

  • the present invention relates to medical pumps for delivering medicament to a patient, and more specifically, to a user-wearable pump.
  • One category of devices for delivering such fluids is that of pumps that have been developed for the administration of insulin and other medicaments for those suffering from both type I and type II diabetes.
  • Some pumps configured as portable infusion devices can provide continuous subcutaneous medicament injection and/or infusion therapy for the treatment of diabetes.
  • Such therapy may include, e.g., the regular and/or continuous injection or infusion of insulin into the skin of a person suffering from diabetes and offer an alternative to multiple daily injections of insulin by an insulin syringe or an insulin pen.
  • Such pumps can be ambulatory/portable infusion pumps that are worn by the user and may use replaceable cartridges. Examples of such pumps and various features that can be associated with such pumps include those disclosed in U.S. Patent Application Publication No. 2013/0053816; U.S. Pat.
  • Patch pumps are small pumps, typically ambulatory, that may be carried directly on the skin under the user's clothing. In some cases, the pumps are situated directly on, or very near to, the injection site such that little or no tubing is required to deliver the insulin or other medicament to the patient.
  • Some patch pumps include a single button on the pump to initiate delivery of medicament and do not include a built-in display or user interface. These pumps are therefore primarily remote-controlled. Having only a single button on the pump provides the advantage of being more robust for waterproofing and resistance to external contaminants.
  • a disadvantage is that the functionality of a pump with a single button is limited without the use of a remote control apparatus, typically including a user interface.
  • Embodiments of the present disclosure enable enhanced or altered functionality of an infusion pump in the presence of a recognized electromagnetic signal or following a predefined sequence of accelerometer-detected orientation shifts.
  • activation of at least one button on the pump normally initiates a first function or operation, such as initiating delivery of medicament, but in the presence of a recognized electromagnetic signal or following a predefined sequence of accelerometer-detected orientation shifts, the at least one button can initiate a second function or operation different from the first function, such as pairing the pump to a remote device.
  • This can expand the number of functions that can be accomplished with a device that has a limited number of means for inputting commands into the device.
  • One embodiment of the present disclosure provides an infusion pump system including a pump for delivering medicament to a user of the pump.
  • the pump can have a wirelessly chargeable battery and at least one button.
  • activation of the at least one button can enable and/or initiate a first function or operation.
  • activation of the at least one button can enable and/or initiate a second, different function or operation.
  • an infusion pump system including a pump for delivering medicament to a user of the pump.
  • the pump can include a Bluetooth beacon receiver and at least one button.
  • activation of the at least one button can enable and/or initiate a first function or operation.
  • activation of the at least one button can enable and/or initiate a second, different function or operation.
  • an infusion pump system including a pump having for delivering medicament to a user of the pump.
  • the pump can include a plurality of accelerometers that are configured to sense acceleration and detect pump orientation and at least one button. Activation of the at least one button can enable and/or initiate a first function or operation, but following a predefined sequence of accelerometer-detected orientation shifts, activation of the at least one button can enable and/or initiate a second, different function or operation.
  • activation of the at least one button can be at least one of a single press of the at least one button or a predefined sequential pattern of presses of the at least one button over a determined length of time.
  • the first function can be at least one of initiating delivery of medicament, communicatively coupling the pump to a remote display and/or user interface, communicatively coupling the pump to a remote glucose monitor, or initiating a status check.
  • the second function can be at least one of suspending delivery of medicament, initiating a low-power mode for the pump, resetting the pump, communicatively coupling the pump to a remote display and/or user interface, communicatively coupling the pump to a remote glucose monitor, or initiating a test routine.
  • FIGS. 1A-1C depicts an embodiment of a pump system according to the disclosure.
  • FIGS. 2A-2B depict an embodiment of a pump system according to the disclosure.
  • FIG. 3 depicts an embodiment of a pump system according to the disclosure.
  • FIGS. 4A-4B depict remote control devices for a pump system according to embodiments of the disclosure.
  • FIGS. 5A-5D depict a procedure for inductively charging a battery of a pump system according to an embodiment of the disclosure.
  • FIG. 6 depicts a method of altering or enhancing the functionality of a pump system according to embodiments of the disclosure.
  • a pump system 100 including a pump 102 is depicted in accordance with an embodiment of the disclosure.
  • Drive unit 118 of pump 102 includes a drive mechanism 122 that mates with a recess in medicament cartridge 116 of pump 102 to attach the medicament cartridge 116 to the drive unit 118 .
  • the drive unit 118 cooperates with the medicament cartridge to provide a delivery mechanism for delivery of medicament, such as insulin, from a reservoir in the medicament cartridge 116 to a user through, e.g., a cannula.
  • medicament such as insulin
  • Cartridge 116 of pump 102 can attach to drive unit 118 with, for example, a quarter turn attachment mechanism.
  • the recess of cartridge 116 can be configured to initially attach to drive mechanism 122 of drive unit 118 such that an outer front housing surface 140 of the cartridge 116 is offset from an outer front housing surface 142 of the drive unit 118 and an angle of, e.g., between about 30 and about 150 degrees.
  • the cartridge 116 can then be rotated toward the drive unit 118 to align the outer surface 140 of the cartridge 116 generally parallel with the outer surface 142 of the drive unit 118 and secure the cartridge 116 on the drive unit 118 .
  • the engagement of the cartridge 116 to the drive unit 118 made by this rotation can cause an audible clicking sound that provides an auditory indication to the user that the cartridge is properly attached by the user of, e.g., detent projections and grooves as depicted.
  • Such a feature can alternatively or additionally provide a tactile indication to the user that the cartridge is properly attached.
  • pump system 100 can include a short length of tubing 153 and a connector 152 .
  • Connector 152 can be configured to attach to a corresponding connector of an infusion set that includes, e.g., a length of tubing extending from the corresponding connector to an infusion site having an infusion site connector to deliver medicament to the infusion site.
  • connector 152 extending from cartridge 116 and the corresponding connector of the infusion set can be Luer Lock connections.
  • Other infusion set configurations and attachments are described in U.S. Patent Publication No. 2014/0276423, which is hereby incorporated by reference in its entirety.
  • pump system 100 can include a pump 102 and an infusion set 145 .
  • FIG. 2A depicts this infusion set 145 as not connected to pump while FIG. 2B depicts infusion set 145 connected to pump 102 via connectors 154 and 152 .
  • Infusion set 145 can include tubing 144 extending between a connector 154 and a site connector 146 .
  • Connector 154 can be configured to couple to pump 102 at connector 152 .
  • Site connector 146 can be configured to be attached to an infusion site on a user, while pump 102 can be carried in a separate location, such as the user's pocket (as depicted in FIG. 3 ).
  • Various lengths of tubing 144 can be used in this embodiment to accommodate the user's preference.
  • pump 102 includes a processor that controls operations of the pump and, in some embodiments, may communicate in either one-way or two-way modes to, e.g., receive operational commands and/or other signals, including data, from a separate device and/or, e.g., to send signals, including data, to a separate device.
  • Pump 102 can include one or more buttons configured to cause the processor to initiate one or more functions.
  • pump 102 includes only a single button 172 , although more than one button may be present on pump 102 .
  • Button 172 can be configured to, for example, initiate delivery of medicament. Any single button such as button 172 can be utilized to execute a plurality of functions or operations.
  • buttons 172 may initiate one function, holding the button down for a predetermined period of time may initiate another function, etc.
  • the depicted pump 102 optionally does not itself include a display or user interface, information and feedback regarding medicament delivery or dosing initiated with button 172 can be communicated to and displayed on a remote control device or other device having a display and/or other type of user interface.
  • pump 102 includes a light source, such as a light emitting diode (LED) 174 .
  • Light source 174 can be configured to provide user feedback regarding user input and/or the performance of a desired function.
  • light source 174 can illuminate or blink one or more times to indicate that the one or more buttons 172 have been activated and/or that a desired function has been initiated.
  • pump 102 can additionally and/or alternatively vibrate and/or provide audible notifications to indicate that the one or more buttons 172 have been activated and/or that a desired function has been initiated or, e.g., to provide user feedback regarding user input and/or the performance of the desired function.
  • Illumination of light source 174 and/or vibrations and/or audible notifications may be executed in any number of patterns, frequencies, durations, sequences, combinations, colors, brightness levels, etc. to indicate particular information, such as particular input received and/or particular functions or operations enabled and/or initiated, to the pump user or caregiver.
  • one or more remote control devices 170 , 171 can be used to communicate with the processor of pump 102 to control delivery of medicament and transfer data with pump 102 via a wired or a wireless electromagnetic signal, such as via, e.g., a near field communication (NFC) radio frequency (RF) modality or other RF modalities such as Bluetooth®, Bluetooth® low energy, mobile or Wi-Fi communication protocols, for example, according to embodiments of the present disclosure.
  • a remote control can include, for example, a mobile communication device 170 , such as a smart phone (as depicted in FIG. 3 ) executing a software application for control of the pump, a dedicated remote controller 171 (as depicted in FIGS.
  • Such communications between (and among) the one or more remote control devices 170 , 171 and pump 102 may be one-way or two-way for, e.g., effective transfer of data among the devices and the pump, control of pump operations, updating software on the devices and/or pump, and allowing pump-related data to be viewed on the devices and/or pump.
  • a dedicated remote controller 171 can include a display or user interface such as a touchscreen display 173 .
  • Touchscreen 173 can, in various embodiments, include a color display and can be a capacitive touchscreen, resistive touchscreen, or the like and can be a single touch or multitouch touchscreen.
  • Dedicated remote controller 171 can further include one or more touch sensitive buttons 175 , a pushbutton 177 and a port 179 .
  • touch sensitive button 175 can be configured to return the controller 171 to a home screen from another menu screen any time the button 175 is touched and the pushbutton 177 can be configured to wake the device from a sleep or off mode and activate the display 173 anytime the button 177 is pressed.
  • these functions can be reversed or both functions can be accomplished with a single button depending on the current state of the device.
  • Port 179 can be any type of port known in the art for data transfer and charging of a rechargeable battery in the controller 171 , such as, for example, a hardware interface such as a USB port, Thunderbolt® port, etc.
  • Controller 171 can additionally include one or more of a speaker/microphone, vibrator and/or light, such as an LED, for providing alerts, alarms, notifications, voice inputs/commands, etc., single or in various combinations as previously described.
  • pumps described herein can interface with a glucose meter, such as a blood glucose meter (BGM) or a continuous glucose monitor (CGM), the latter category of which provides a substantially continuous estimated of a blood glucose level through a transcutaneous sensor that measures analytes, such as glucose, in the patient's interstitial fluid rather than the patient's blood.
  • BGM blood glucose meter
  • CGM continuous glucose monitor
  • Pump system can use data obtained from a glucose meter such as a CGM to adjust therapy with pump either automatically, such as in a closed-loop or semi-closed loop “artificial pancreas” system, or by providing such data for user review via a remote control device 170 , 171 .
  • the data may be transmitted from the CGM to the pump and/or remote controller via a wireless transmitter, such as an NFC RF transmitter or an RF transmitter operating according to a “Wi-Fi” or Bluetooth® protocol or the like, or the data may be transmitted via a wire connector.
  • a wireless transmitter such as an NFC RF transmitter or an RF transmitter operating according to a “Wi-Fi” or Bluetooth® protocol or the like
  • the data may be transmitted via a wire connector.
  • Embodiments of the present invention include components capable of and methods using wired and wireless transmission and receipt of signals for exchange of information and commands between and among any of the components as described herein, including, e.g., between a pump and a smartphone; among a pump, a CGM and a smartphone; between a dedicated remote controller and a pump; among a dedicated remote controller, a CGM and a pump; among a dedicated remote controller, a BGM and a pump, and other combinations as would be contemplated by those of skill in the art.
  • pumps can include one or more rechargeable batteries in and/or associated with the pump drive unit 118 .
  • a rechargeable battery can be wirelessly charged, for example through inductive charging by an inductive charging pad 180 .
  • the charging pad 180 can include a cover 182 having a cutout sized to receive pump 102 in order to properly position and retain pump 102 on the charging pad 180 during recharging.
  • the charging pad 180 may receive power by being connected to a wall outlet.
  • the charging pad 180 may additionally or alternatively include a wired and/or wireless power connection to, for example, a computer (e.g., via USB or IEEE 1394), a 12 volt automobile outlet, a battery pack (e.g., via USB or IEEE 1394), optical means, and a solar panel, among others.
  • a computer e.g., via USB or IEEE 1394
  • a battery pack e.g., via USB or IEEE 1394
  • optical means e.g., via USB or IEEE 1394
  • solar panel e.g., a solar panel, among others.
  • the pump 102 may first be disconnected from the tubing of the infusion set (as depicted in FIG. 5C ). The pump can then be placed onto the charging pad 180 (as depicted in FIG. 5D ), where its battery will automatically be inductively (re)charged when the pad 180 is connected to a power source. In another embodiment, the pump 102 can remain connected to the infusion set and the user while the battery is recharging. In some embodiments, a pump that can be inductively or otherwise wirelessly charged does not include an external connection port, such as a USB or IEEE 1394 port, into which a power cord can be inserted for power transfer. Such an embodiment provides the advantages of being more robust for waterproofing because of the lack of exposed electrical contacts and obviating electrical isolation requirements imposed upon such connections.
  • Inductive charging of pump 102 can be carried out according to known standards, such as, for example, the Qi open interface standard.
  • both the pump 102 and the charging pad 180 include an inductive coil.
  • a transmitting coil in the charging pad 180 connected to the power source generates an oscillating magnetic field that induces an alternating current in a receiving coil in the pump 102 to transfer power to pump 102 .
  • charging pad 180 continuously (e.g., twice a second) sends an analog signal to detect the presence of a device such as pump 102 .
  • the pad detects the presence of, e.g., a pump (via a magnetic load), it sends a digital communication signal to the pump 102 .
  • the pump receives the signal and sends a return signal to the pad 180 , which causes the pad 180 to transmit charging power to the pump.
  • buttons 172 can be configured to enable and/or initiate a first function or operation (i.e., function A).
  • the first function can be at least one of, for example, initiating a medicament bolus or delivery of medicament, communicatively coupling the pump to a remote display and/or user interface, communicatively coupling the pump to a remote glucose monitor, initiating a status check, etc.
  • a single press of button 172 initiates medicament delivery, while a predefined sequential pattern of presses of button 172 over a determined length of time communicatively couples the pump 102 to a remote control device 170 or dedicated remote controller 171 .
  • light source 174 such as an LED, can illuminate to indicate that button 172 has been activated and/or function A has been initiated.
  • a recognized electromagnetic signal is received by pump 102 from another device.
  • the received electromagnetic signal can be a wireless charging signal such as an inductive charging signal.
  • the inductive charging methodology can require that the pump 102 detect the presence of a charging pad 180 when the charging pad 180 and the pump 102 are in close enough proximity for energy transfer via electromagnetic induction to occur.
  • This communication between the charging pad 180 and the pump 102 sometimes referred to as a “handshake,” can aid in ensuring that the charging pad 180 only transmits an inductive charging signal when the pump 102 is present and its battery is ready to receive a charge, and cease transmission once the rechargeable battery has been fully charged, thereby avoiding energy waste and battery overcharging.
  • the wireless or inductive “charging signal” as used herein with regard to embodiments of the invention can in various embodiments refer to either the presence detecting signal sent out by the pad to detect the pump, the electromagnetic field or other signal transmitted by the pad to charge the pump, an additional signal transmitted continuously or periodically transmitted by the pad when, for example, the pad is idle or a charge is complete, or some combination thereof.
  • the received electromagnetic signal can be recognized as an input to software on the pump 102 operated by the pump processor to enable additional features of the pump, either on its own, or in combination with activation of button 172 .
  • activation of button 172 can be configured to enable and/or initiate a second function or operation (i.e., function B) different from the first function or operation when the inductive charging signal is present.
  • the second function can be at least one of, for example, suspending delivery of medicament, initiating a low-power or shelf mode for the pump, resetting the pump processor, communicatively coupling the pump to a remote display and/or user interface, communicatively coupling the pump to a remote glucose monitor, initiating a test routine, initiating a software update protocol, etc.
  • a single press of button 172 in the presence of inductive charging signal suspends delivery of medicament, while a predefined sequential pattern of presses of button 172 over a determined length of time communicatively resets the pump 102 .
  • light source 174 can illuminate to indicate that button 172 has been activated and/or function B has been initiated.
  • buttons 172 may cause the device to execute first and second functions depending on whether or not an electromagnetic signal is present as described herein, whereas a different type of activation of button 172 , such, as for example, holding the button down for a predetermined period of time or pressing button 172 a number times within a certain period (e.g., two or three button presses in rapid succession or otherwise recognizable pattern/frequency) can initiate third and fourth or more functions in the absence and presence of such a signal, respectively.
  • a predetermined period of time or pressing button 172 a number times within a certain period (e.g., two or three button presses in rapid succession or otherwise recognizable pattern/frequency) can initiate third and fourth or more functions in the absence and presence of such a signal, respectively.
  • pumps as described herein could alternatively or additionally be charged with resonant wireless charging and RF-based wireless charging and utilize signals related thereto to alter functionality of the pump as described herein.
  • the received electromagnetic signal can be a Bluetooth beacon, such as that emitted from the remote control device 170 or dedicated remote controller 171 .
  • a Bluetooth beacon such as that emitted from the remote control device 170 or dedicated remote controller 171 .
  • Such an emitted beacon can have a unique address or name that is recognizable to the pump software when placed within a receivable range of pump 102 .
  • pump 102 is equipped with one or more accelerometers configured to detect or sense acceleration and/or pump orientation, the input of which can enhance or alter the functionality of button 172 , in place of or in addition to an electromagnetic signal.
  • a user can shake the pump 102 , either continuously, or for a specified number of times.
  • the one or more accelerometers can detect the pump orientation based on the current orientation or a sequence of orientation shifts.
  • the pump can be held in a vertical orientation until a timeout is achieved, wherein the pump can beep or vibrate to indicate that the time requirement has been met.
  • the pump can then be rotated between about 90 and about 180 degrees to a secondary position and held in that position until a second timeout is achieved.
  • This sequence of orientation shifts can be used to enable pump features and can be useful in production or during patient use for tasks such as cartridge change or priming, to ensure that the pump 102 is in the optimal orientation.
  • the sensed accelerations can be recognized as inputs to software on the pump 102 to enable additional features of the pump, either on its own, or in combination with activation of button 172 .
  • button 172 can be increased, while still maintaining an overall usability of pump 102 that is both intuitive and safe for a user.
  • Embodiments of the present disclosure enable enhanced or altered operation and/or functionality of an infusion pump, such as a user-wearable infusion pump, in the presence of a recognized electromagnetic signal or following a predefined sequence of accelerometer detected orientation shifts.
  • activation of at least one button on the pump normally enables and/or initiates a first function or operation, such as enabling and/or initiating delivery of medicament, but in the presence of a recognized electromagnetic signal or following a predefined sequence of accelerometer detected orientation shifts, the at least one button can enable and/or initiate a second function or operation different from the first function, such as pairing the pump to a remote device.
  • the pump system described herein is described as a user-wearable pump system that has no display or user interface and is primarily controlled by a remote device, it should be understood that aspects of the present disclosure can be incorporated into other types of infusion pumps.
  • full-featured user-wearable infusion pumps having display and input capabilities, such as a touchscreen display on the pump housing one example of which is disclosed in U.S. Pat. No. 8,287,495, which is hereby incorporated by reference herein, can incorporate aspects of the present disclosure.

Abstract

A user-wearable infusion pump system includes an inductively or otherwise wirelessly chargeable battery and at least one button. Activation of the at least one button when not in the presence of an inductive charging signal can enable and/or initiate a first function or operation and activation of the at least one button in the presence of an inductive charging signal can enable and/or initiate a different, second function or operation. Such functionality can also be enabled in the presence of other types of electromagnetic signals.

Description

    RELATED APPLICATION
  • This application is a continuation of application Ser. No. 15/868,461 filed Jan. 11, 2018, which claims the benefit of U.S. Provisional Application No. 62/445,041 filed Jan. 11, 2017, each of which is hereby incorporated herein in its entirety by reference.
  • TECHNICAL FIELD
  • The present invention relates to medical pumps for delivering medicament to a patient, and more specifically, to a user-wearable pump.
  • BACKGROUND
  • There are many applications in academic, industrial, and medical fields that benefit from devices and methods that are capable of accurately and controllably delivering fluids, such as liquids and gases, that have a beneficial effect when administered in known and controlled quantities. Such devices and methods can be particularly useful in the medical field where treatments for many patients include the administration of a known amount of a substance at predetermined intervals.
  • One category of devices for delivering such fluids is that of pumps that have been developed for the administration of insulin and other medicaments for those suffering from both type I and type II diabetes. Some pumps configured as portable infusion devices can provide continuous subcutaneous medicament injection and/or infusion therapy for the treatment of diabetes. Such therapy may include, e.g., the regular and/or continuous injection or infusion of insulin into the skin of a person suffering from diabetes and offer an alternative to multiple daily injections of insulin by an insulin syringe or an insulin pen. Such pumps can be ambulatory/portable infusion pumps that are worn by the user and may use replaceable cartridges. Examples of such pumps and various features that can be associated with such pumps include those disclosed in U.S. Patent Application Publication No. 2013/0053816; U.S. Pat. Nos. 8,573,027; 8,986,253; U.S. Patent Application Publication No. 2013/0324928; U.S. Patent Application Publication No. 2013/0331790; U.S. Pat. No. 8,287,495; U.S. patent application Ser. No. 15/241,257 (filed Aug. 19, 2016); and U.S. patent application Ser. No. 15/158,125 (filed May 18, 2016), each of which is hereby incorporated herein by reference in its entirety.
  • One type of pump that has been developed is a patch pump, or micro pump. Patch pumps are small pumps, typically ambulatory, that may be carried directly on the skin under the user's clothing. In some cases, the pumps are situated directly on, or very near to, the injection site such that little or no tubing is required to deliver the insulin or other medicament to the patient. Some patch pumps include a single button on the pump to initiate delivery of medicament and do not include a built-in display or user interface. These pumps are therefore primarily remote-controlled. Having only a single button on the pump provides the advantage of being more robust for waterproofing and resistance to external contaminants. However, a disadvantage is that the functionality of a pump with a single button is limited without the use of a remote control apparatus, typically including a user interface.
  • SUMMARY
  • Embodiments of the present disclosure enable enhanced or altered functionality of an infusion pump in the presence of a recognized electromagnetic signal or following a predefined sequence of accelerometer-detected orientation shifts. For example, activation of at least one button on the pump normally initiates a first function or operation, such as initiating delivery of medicament, but in the presence of a recognized electromagnetic signal or following a predefined sequence of accelerometer-detected orientation shifts, the at least one button can initiate a second function or operation different from the first function, such as pairing the pump to a remote device. This can expand the number of functions that can be accomplished with a device that has a limited number of means for inputting commands into the device.
  • One embodiment of the present disclosure provides an infusion pump system including a pump for delivering medicament to a user of the pump. The pump can have a wirelessly chargeable battery and at least one button. When not in the presence of a wireless charging signal, activation of the at least one button can enable and/or initiate a first function or operation. When in the presence of a wireless charging signal, activation of the at least one button can enable and/or initiate a second, different function or operation.
  • Another embodiment of the present disclosure provides an infusion pump system including a pump for delivering medicament to a user of the pump. The pump can include a Bluetooth beacon receiver and at least one button. When not in the presence of a Bluetooth beacon, activation of the at least one button can enable and/or initiate a first function or operation. When in the presence of a Bluetooth beacon, activation of the at least one button can enable and/or initiate a second, different function or operation.
  • Another embodiment of the present disclosure provides an infusion pump system including a pump having for delivering medicament to a user of the pump. The pump can include a plurality of accelerometers that are configured to sense acceleration and detect pump orientation and at least one button. Activation of the at least one button can enable and/or initiate a first function or operation, but following a predefined sequence of accelerometer-detected orientation shifts, activation of the at least one button can enable and/or initiate a second, different function or operation.
  • In one embodiment, activation of the at least one button can be at least one of a single press of the at least one button or a predefined sequential pattern of presses of the at least one button over a determined length of time. In one embodiment, the first function can be at least one of initiating delivery of medicament, communicatively coupling the pump to a remote display and/or user interface, communicatively coupling the pump to a remote glucose monitor, or initiating a status check. In one embodiment, the second function can be at least one of suspending delivery of medicament, initiating a low-power mode for the pump, resetting the pump, communicatively coupling the pump to a remote display and/or user interface, communicatively coupling the pump to a remote glucose monitor, or initiating a test routine.
  • The above summary is not intended to describe each illustrated embodiment or every implementation of the subject matter hereof. The figures and the detailed description that follow more particularly exemplify various embodiments.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Subject matter hereof may be more completely understood in consideration of the following detailed description of various embodiments in connection with the accompanying figures, in which:
  • FIGS. 1A-1C depicts an embodiment of a pump system according to the disclosure.
  • FIGS. 2A-2B depict an embodiment of a pump system according to the disclosure.
  • FIG. 3 depicts an embodiment of a pump system according to the disclosure.
  • FIGS. 4A-4B depict remote control devices for a pump system according to embodiments of the disclosure.
  • FIGS. 5A-5D depict a procedure for inductively charging a battery of a pump system according to an embodiment of the disclosure.
  • FIG. 6 depicts a method of altering or enhancing the functionality of a pump system according to embodiments of the disclosure.
  • While various embodiments are amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the claimed inventions to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the subject matter as defined by the claims.
  • DETAILED DESCRIPTION OF THE DRAWINGS
  • Referring to FIGS. 1A-1C, a pump system 100 including a pump 102 is depicted in accordance with an embodiment of the disclosure. Drive unit 118 of pump 102 includes a drive mechanism 122 that mates with a recess in medicament cartridge 116 of pump 102 to attach the medicament cartridge 116 to the drive unit 118. The drive unit 118 cooperates with the medicament cartridge to provide a delivery mechanism for delivery of medicament, such as insulin, from a reservoir in the medicament cartridge 116 to a user through, e.g., a cannula. Further details regarding example embodiments of such delivery mechanisms can be found in U.S. Patent Publication No. 2017/0049957, which is hereby incorporated by reference in its entirety.
  • Cartridge 116 of pump 102 can attach to drive unit 118 with, for example, a quarter turn attachment mechanism. The recess of cartridge 116 can be configured to initially attach to drive mechanism 122 of drive unit 118 such that an outer front housing surface 140 of the cartridge 116 is offset from an outer front housing surface 142 of the drive unit 118 and an angle of, e.g., between about 30 and about 150 degrees. The cartridge 116 can then be rotated toward the drive unit 118 to align the outer surface 140 of the cartridge 116 generally parallel with the outer surface 142 of the drive unit 118 and secure the cartridge 116 on the drive unit 118. In one embodiment, the engagement of the cartridge 116 to the drive unit 118 made by this rotation can cause an audible clicking sound that provides an auditory indication to the user that the cartridge is properly attached by the user of, e.g., detent projections and grooves as depicted. Such a feature can alternatively or additionally provide a tactile indication to the user that the cartridge is properly attached. Further details regarding such pumps can be found in U.S. patent application Ser. No. 14/707,851 (filed May 8, 2015); U.S. Patent Application Publication No. 2016/0339172; and U.S. Patent Application Publication No. 2017/0049957, each of which is hereby incorporated herein by reference in its entirety.
  • In one embodiment, pump system 100 can include a short length of tubing 153 and a connector 152. Connector 152 can be configured to attach to a corresponding connector of an infusion set that includes, e.g., a length of tubing extending from the corresponding connector to an infusion site having an infusion site connector to deliver medicament to the infusion site. In some embodiments, connector 152 extending from cartridge 116 and the corresponding connector of the infusion set can be Luer Lock connections. Other infusion set configurations and attachments are described in U.S. Patent Publication No. 2014/0276423, which is hereby incorporated by reference in its entirety.
  • As depicted in the embodiment of FIGS. 2A-2B, pump system 100 can include a pump 102 and an infusion set 145. FIG. 2A depicts this infusion set 145 as not connected to pump while FIG. 2B depicts infusion set 145 connected to pump 102 via connectors 154 and 152. Infusion set 145 can include tubing 144 extending between a connector 154 and a site connector 146. Connector 154 can be configured to couple to pump 102 at connector 152. Site connector 146 can be configured to be attached to an infusion site on a user, while pump 102 can be carried in a separate location, such as the user's pocket (as depicted in FIG. 3). Various lengths of tubing 144 can be used in this embodiment to accommodate the user's preference.
  • In one embodiment, pump 102 includes a processor that controls operations of the pump and, in some embodiments, may communicate in either one-way or two-way modes to, e.g., receive operational commands and/or other signals, including data, from a separate device and/or, e.g., to send signals, including data, to a separate device. Pump 102 can include one or more buttons configured to cause the processor to initiate one or more functions. In the depicted embodiments, pump 102 includes only a single button 172, although more than one button may be present on pump 102. Button 172 can be configured to, for example, initiate delivery of medicament. Any single button such as button 172 can be utilized to execute a plurality of functions or operations. For example, a single press of button may initiate one function, holding the button down for a predetermined period of time may initiate another function, etc. Because the depicted pump 102 optionally does not itself include a display or user interface, information and feedback regarding medicament delivery or dosing initiated with button 172 can be communicated to and displayed on a remote control device or other device having a display and/or other type of user interface.
  • In one embodiment, pump 102 includes a light source, such as a light emitting diode (LED) 174. Light source 174 can be configured to provide user feedback regarding user input and/or the performance of a desired function. For example, in one embodiment, light source 174 can illuminate or blink one or more times to indicate that the one or more buttons 172 have been activated and/or that a desired function has been initiated. In one embodiment, pump 102 can additionally and/or alternatively vibrate and/or provide audible notifications to indicate that the one or more buttons 172 have been activated and/or that a desired function has been initiated or, e.g., to provide user feedback regarding user input and/or the performance of the desired function. Illumination of light source 174 and/or vibrations and/or audible notifications may be executed in any number of patterns, frequencies, durations, sequences, combinations, colors, brightness levels, etc. to indicate particular information, such as particular input received and/or particular functions or operations enabled and/or initiated, to the pump user or caregiver.
  • Referring to FIGS. 3-4B, one or more remote control devices 170, 171 can be used to communicate with the processor of pump 102 to control delivery of medicament and transfer data with pump 102 via a wired or a wireless electromagnetic signal, such as via, e.g., a near field communication (NFC) radio frequency (RF) modality or other RF modalities such as Bluetooth®, Bluetooth® low energy, mobile or Wi-Fi communication protocols, for example, according to embodiments of the present disclosure. Such a remote control can include, for example, a mobile communication device 170, such as a smart phone (as depicted in FIG. 3) executing a software application for control of the pump, a dedicated remote controller 171 (as depicted in FIGS. 4A-4B), a wearable electronic watch or electronic health or fitness monitor or personal digital assistant (PDA), etc., or a tablet, laptop or personal computer. Such communications between (and among) the one or more remote control devices 170, 171 and pump 102 may be one-way or two-way for, e.g., effective transfer of data among the devices and the pump, control of pump operations, updating software on the devices and/or pump, and allowing pump-related data to be viewed on the devices and/or pump.
  • Referring to FIGS. 4A-4B for instance, a dedicated remote controller 171 according to embodiments of the disclosure can include a display or user interface such as a touchscreen display 173. Touchscreen 173 can, in various embodiments, include a color display and can be a capacitive touchscreen, resistive touchscreen, or the like and can be a single touch or multitouch touchscreen. Dedicated remote controller 171 can further include one or more touch sensitive buttons 175, a pushbutton 177 and a port 179. In some embodiments, touch sensitive button 175 can be configured to return the controller 171 to a home screen from another menu screen any time the button 175 is touched and the pushbutton 177 can be configured to wake the device from a sleep or off mode and activate the display 173 anytime the button 177 is pressed. In other embodiments, these functions can be reversed or both functions can be accomplished with a single button depending on the current state of the device. Port 179 can be any type of port known in the art for data transfer and charging of a rechargeable battery in the controller 171, such as, for example, a hardware interface such as a USB port, Thunderbolt® port, etc. Controller 171 can additionally include one or more of a speaker/microphone, vibrator and/or light, such as an LED, for providing alerts, alarms, notifications, voice inputs/commands, etc., single or in various combinations as previously described.
  • In some embodiments, pumps described herein can interface with a glucose meter, such as a blood glucose meter (BGM) or a continuous glucose monitor (CGM), the latter category of which provides a substantially continuous estimated of a blood glucose level through a transcutaneous sensor that measures analytes, such as glucose, in the patient's interstitial fluid rather than the patient's blood. Pump system can use data obtained from a glucose meter such as a CGM to adjust therapy with pump either automatically, such as in a closed-loop or semi-closed loop “artificial pancreas” system, or by providing such data for user review via a remote control device 170, 171. The data may be transmitted from the CGM to the pump and/or remote controller via a wireless transmitter, such as an NFC RF transmitter or an RF transmitter operating according to a “Wi-Fi” or Bluetooth® protocol or the like, or the data may be transmitted via a wire connector. Further detail regarding CGM systems and definitions of related terms can be found in, e.g., U.S. Pat. Nos. 8,311,749, 7,711,402 and 7,497,827, each of which is hereby incorporated by reference in its entirety.
  • Embodiments of the present invention include components capable of and methods using wired and wireless transmission and receipt of signals for exchange of information and commands between and among any of the components as described herein, including, e.g., between a pump and a smartphone; among a pump, a CGM and a smartphone; between a dedicated remote controller and a pump; among a dedicated remote controller, a CGM and a pump; among a dedicated remote controller, a BGM and a pump, and other combinations as would be contemplated by those of skill in the art.
  • Referring to FIGS. 5A-5C, pumps according to embodiments of the present disclosure can include one or more rechargeable batteries in and/or associated with the pump drive unit 118. In some embodiments, a rechargeable battery can be wirelessly charged, for example through inductive charging by an inductive charging pad 180. As depicted in FIG. 5B, in some embodiments, the charging pad 180 can include a cover 182 having a cutout sized to receive pump 102 in order to properly position and retain pump 102 on the charging pad 180 during recharging. In some embodiments, as shown in FIGS. 5A, 5B, 5D, the charging pad 180 may receive power by being connected to a wall outlet. In other embodiments, the charging pad 180 may additionally or alternatively include a wired and/or wireless power connection to, for example, a computer (e.g., via USB or IEEE 1394), a 12 volt automobile outlet, a battery pack (e.g., via USB or IEEE 1394), optical means, and a solar panel, among others.
  • To charge the pump 102, the pump 102 may first be disconnected from the tubing of the infusion set (as depicted in FIG. 5C). The pump can then be placed onto the charging pad 180 (as depicted in FIG. 5D), where its battery will automatically be inductively (re)charged when the pad 180 is connected to a power source. In another embodiment, the pump 102 can remain connected to the infusion set and the user while the battery is recharging. In some embodiments, a pump that can be inductively or otherwise wirelessly charged does not include an external connection port, such as a USB or IEEE 1394 port, into which a power cord can be inserted for power transfer. Such an embodiment provides the advantages of being more robust for waterproofing because of the lack of exposed electrical contacts and obviating electrical isolation requirements imposed upon such connections.
  • Inductive charging of pump 102 can be carried out according to known standards, such as, for example, the Qi open interface standard. In an example of such a system, both the pump 102 and the charging pad 180 include an inductive coil. A transmitting coil in the charging pad 180 connected to the power source generates an oscillating magnetic field that induces an alternating current in a receiving coil in the pump 102 to transfer power to pump 102. In one embodiment, charging pad 180 continuously (e.g., twice a second) sends an analog signal to detect the presence of a device such as pump 102. When the pad detects the presence of, e.g., a pump (via a magnetic load), it sends a digital communication signal to the pump 102. The pump receives the signal and sends a return signal to the pad 180, which causes the pad 180 to transmit charging power to the pump.
  • Referring to FIG. 6, a method of enhancing or altering the operation and/or functionality of a single button 172 in the presence of an external electromagnetic signal is depicted in accordance with an embodiment of the disclosure. In other embodiments, the method can alter the function of a plurality of buttons. In one embodiment, at step 201, activation of button 172 can be configured to enable and/or initiate a first function or operation (i.e., function A). The first function can be at least one of, for example, initiating a medicament bolus or delivery of medicament, communicatively coupling the pump to a remote display and/or user interface, communicatively coupling the pump to a remote glucose monitor, initiating a status check, etc. For example, in one embodiment, a single press of button 172 initiates medicament delivery, while a predefined sequential pattern of presses of button 172 over a determined length of time communicatively couples the pump 102 to a remote control device 170 or dedicated remote controller 171. In one embodiment, light source 174, such as an LED, can illuminate to indicate that button 172 has been activated and/or function A has been initiated.
  • At step 202, a recognized electromagnetic signal is received by pump 102 from another device. For example, the received electromagnetic signal can be a wireless charging signal such as an inductive charging signal. In one embodiment, the inductive charging methodology can require that the pump 102 detect the presence of a charging pad 180 when the charging pad 180 and the pump 102 are in close enough proximity for energy transfer via electromagnetic induction to occur. This communication between the charging pad 180 and the pump 102, sometimes referred to as a “handshake,” can aid in ensuring that the charging pad 180 only transmits an inductive charging signal when the pump 102 is present and its battery is ready to receive a charge, and cease transmission once the rechargeable battery has been fully charged, thereby avoiding energy waste and battery overcharging. It is noted that the wireless or inductive “charging signal” as used herein with regard to embodiments of the invention can in various embodiments refer to either the presence detecting signal sent out by the pad to detect the pump, the electromagnetic field or other signal transmitted by the pad to charge the pump, an additional signal transmitted continuously or periodically transmitted by the pad when, for example, the pad is idle or a charge is complete, or some combination thereof.
  • The received electromagnetic signal can be recognized as an input to software on the pump 102 operated by the pump processor to enable additional features of the pump, either on its own, or in combination with activation of button 172. Thus, at step 203, activation of button 172 can be configured to enable and/or initiate a second function or operation (i.e., function B) different from the first function or operation when the inductive charging signal is present. In one embodiment, the second function can be at least one of, for example, suspending delivery of medicament, initiating a low-power or shelf mode for the pump, resetting the pump processor, communicatively coupling the pump to a remote display and/or user interface, communicatively coupling the pump to a remote glucose monitor, initiating a test routine, initiating a software update protocol, etc. For example, in one embodiment, a single press of button 172 in the presence of inductive charging signal suspends delivery of medicament, while a predefined sequential pattern of presses of button 172 over a determined length of time communicatively resets the pump 102. In one embodiment, light source 174 can illuminate to indicate that button 172 has been activated and/or function B has been initiated.
  • Although primarily described herein with respect to first and second functions, it should be understood that a plurality of different functions can be addressed by embodiments of the invention. For example, a single press of button 172 may cause the device to execute first and second functions depending on whether or not an electromagnetic signal is present as described herein, whereas a different type of activation of button 172, such, as for example, holding the button down for a predetermined period of time or pressing button 172 a number times within a certain period (e.g., two or three button presses in rapid succession or otherwise recognizable pattern/frequency) can initiate third and fourth or more functions in the absence and presence of such a signal, respectively.
  • In addition, although primarily described herein with regard to inductive charging, embodiments of the invention can utilize other types of wireless charging. For example, pumps as described herein could alternatively or additionally be charged with resonant wireless charging and RF-based wireless charging and utilize signals related thereto to alter functionality of the pump as described herein.
  • In another embodiment, the received electromagnetic signal can be a Bluetooth beacon, such as that emitted from the remote control device 170 or dedicated remote controller 171. Such an emitted beacon can have a unique address or name that is recognizable to the pump software when placed within a receivable range of pump 102.
  • In another embodiment, pump 102 is equipped with one or more accelerometers configured to detect or sense acceleration and/or pump orientation, the input of which can enhance or alter the functionality of button 172, in place of or in addition to an electromagnetic signal. For example, in one embodiment, at step 202, a user can shake the pump 102, either continuously, or for a specified number of times. Alternatively, the one or more accelerometers can detect the pump orientation based on the current orientation or a sequence of orientation shifts. For example, the pump can be held in a vertical orientation until a timeout is achieved, wherein the pump can beep or vibrate to indicate that the time requirement has been met. The pump can then be rotated between about 90 and about 180 degrees to a secondary position and held in that position until a second timeout is achieved. This sequence of orientation shifts can be used to enable pump features and can be useful in production or during patient use for tasks such as cartridge change or priming, to ensure that the pump 102 is in the optimal orientation. The sensed accelerations can be recognized as inputs to software on the pump 102 to enable additional features of the pump, either on its own, or in combination with activation of button 172.
  • Accordingly, through the receipt of a recognized electromagnetic signal and/or input from internal accelerometers, the functionality of button 172 can be increased, while still maintaining an overall usability of pump 102 that is both intuitive and safe for a user.
  • Embodiments of the present disclosure enable enhanced or altered operation and/or functionality of an infusion pump, such as a user-wearable infusion pump, in the presence of a recognized electromagnetic signal or following a predefined sequence of accelerometer detected orientation shifts. For example, activation of at least one button on the pump normally enables and/or initiates a first function or operation, such as enabling and/or initiating delivery of medicament, but in the presence of a recognized electromagnetic signal or following a predefined sequence of accelerometer detected orientation shifts, the at least one button can enable and/or initiate a second function or operation different from the first function, such as pairing the pump to a remote device.
  • Although the pump system described herein is described as a user-wearable pump system that has no display or user interface and is primarily controlled by a remote device, it should be understood that aspects of the present disclosure can be incorporated into other types of infusion pumps. For example, full-featured user-wearable infusion pumps having display and input capabilities, such as a touchscreen display on the pump housing, one example of which is disclosed in U.S. Pat. No. 8,287,495, which is hereby incorporated by reference herein, can incorporate aspects of the present disclosure.
  • Also incorporated herein by reference in their entirety are commonly owned U.S. Pat. Nos. 8,287,495; 8,408,421 8,448,824; 8,573,027; 8,650,937; 8,986,523; 9,173,998; 9,180,242; 9,180,243; 9,238,100; 9,242,043; 9,335,910; 9,381,271; 9,421,329; 9,486,171; 9,486,571; 9,492,608; 9,503,526; 9,555,186; 9,565,718; 9,603,995; 9,669,160; 9,715,327; 9,737,656; and 9,750,871 commonly owned U.S. Patent Publication Nos. 2009/0287180; 2012/0123230; 2013/0053816; 2014/0276419; 2014/0276420; 2014/0276423; 2014/0276531; 2014/0276556 2014/0276569; 2014/0276570; 2014/0378898; 2015/0073337; 2015/0182693; 2016/0082188; 2016/0339172; 2017/0049957; 2017/0142658; 2017/0182248; and 2017/0250971 and commonly owned U.S. patent application Ser. Nos. 14/707,851; 15/564,895; and 15/705,983 and commonly owned U.S. Provisional Application Ser. Nos. 61/911,576; 61/920,902; 61/920,914; 61/920,940; 62/139,275; 62/352,164; 62/445,041; and 62/545,228.
  • Further incorporated by reference herein in their entirety are U.S. Pat. Nos. 8,601,465; 8,502,662; 8,452,953; 8,451,230; 8,449,523; 8,444,595; 8,343,092; 8,285,328; 8,126,728; 8,117,481; 8,095,123; 7,999,674; 7,819,843; 7,782,192; 7,109,878; 6,997,920; 6,979,326; 6,936,029; 6,872,200; 6,813,519; 6,641,533; 6,554,798; 6,551,276; 6,295,506; and 5,665,065.
  • Various embodiments of systems, devices, and methods have been described herein. These embodiments are given only by way of example and are not intended to limit the scope of the claimed inventions. It should be appreciated, moreover, that the various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, configurations and locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the claimed inventions.
  • Persons of ordinary skill in the relevant arts will recognize that the subject matter hereof may comprise fewer features than illustrated in any individual embodiment described above. The embodiments described herein are not meant to be an exhaustive presentation of the ways in which the various features of the subject matter hereof may be combined. Accordingly, the embodiments are not mutually exclusive combinations of features; rather, the various embodiments can comprise a combination of different individual features selected from different individual embodiments, as understood by persons of ordinary skill in the art. Moreover, elements described with respect to one embodiment can be implemented in other embodiments even when not described in such embodiments unless otherwise noted.
  • Although a dependent claim may refer in the claims to a specific combination with one or more other claims, other embodiments can also include a combination of the dependent claim with the subject matter of each other dependent claim or a combination of one or more features with other dependent or independent claims. Such combinations are proposed herein unless it is stated that a specific combination is not intended.
  • Any incorporation by reference of documents above is limited such that no subject matter is incorporated that is contrary to the explicit disclosure herein. Any incorporation by reference of documents above is further limited such that no claims included in the documents are incorporated by reference herein. Any incorporation by reference of documents above is yet further limited such that any definitions provided in the documents are not incorporated by reference herein unless expressly included herein.
  • For purposes of interpreting the claims, it is expressly intended that the provisions of 35 U.S.C. § 112(f) are not to be invoked unless the specific terms “means for” or “step for” are recited in a claim.

Claims (23)

1-20. (canceled)
21. A user-wearable infusion pump, comprising:
a reservoir configured to contain a medicament;
a drive mechanism configured to facilitate delivery of the medicament to a user;
a rechargeable battery configured to be charged wirelessly;
an input button; and
a processor functionally linked to the input button and configured to receive input for control of functions of the user-wearable infusion pump in response to input received via the input button, wherein the processor is configured to:
detect an input received via the input button;
determine whether or not a wireless charging signal was being received by the user-wearable infusion pump at a time that the input was received;
cause the user-wearable infusion pump to execute a first function in response to the input when a wireless charging signal was not being received by the user-wearable infusion pump at the time that the input was received; and
cause the user-wearable infusion pump to execute a second function different from the first function in response to the input when a wireless charging signal was being received by the user-wearable infusion pump at the time that the input was received.
22. The user-wearable infusion pump of claim 21, wherein the pump includes only a single input button.
23. The user-wearable infusion pump of claim 21, wherein the pump does not include a display screen.
24. The user-wearable infusion pump of claim 23, wherein the processor is further configured to wirelessly communicate pump information to a separate device for display on the separate device.
25. The user-wearable infusion pump of claim 21, further comprising an indicator light.
26. The user-wearable infusion pump of claim 25, wherein the indicator light is functionally linked to the input button such that the indicator light illuminates to indicate that input has been received via the input button.
27. The user-wearable infusion pump of claim 26, wherein the indicator light is functionally linked to the input button such that the indicator light illuminates to indicate when the first function is being executed and when the second function is being executed.
28. The user-wearable infusion pump of claim 27, wherein the indicator light is illuminated differently to indicate when the first function is being executed and when the second function is being executed.
29. The user-wearable infusion pump of claim 21, wherein the wireless charging signal is an inductive charging signal.
30. The user-wearable infusion pump of claim 21, wherein the first function is selected from the set consisting of initiating a medicament delivery operation with the user-wearable pump, communicatively coupling the pump with a remote control device, communicatively coupling the pump to a remote glucose monitor and initiating a status check of the user-wearable infusion pump.
31. The user-wearable infusion pump of claim 21, where the second function is selected from the set consisting of suspending delivery of the medicament with the user-wearable infusion pump, initiating a low-power shelf mode for the user-wearable infusion pump, resetting the processor of the user-wearable infusion pump, communicatively coupling the pump with a remote control device, communicatively coupling the pump to a remote glucose monitor, initiating a test routine of the user-wearable infusion pump and initiating a software update protocol.
32. A user-wearable infusion pump, comprising:
a reservoir configured to contain a medicament;
a drive mechanism configured to facilitate delivery of the medicament to a user;
a rechargeable battery configured to be charged wirelessly;
an input button; and
a processor functionally linked to the input button and configured to receive input for control of functions of the user-wearable infusion pump in response to input received via the input button, wherein the processor is configured to:
cause the user-wearable infusion pump to execute a first operating command in response to a first input received via the first input button when a wireless charging signal is not detected by the user-wearable infusion pump when the first input is received, the first operating command causing the user-wearable infusion pump to execute a first function;
cause the user-wearable infusion pump to execute a second operating command causing the user-wearable infusion pump to execute a second function different from the first function when a second input the same as the first input is received when a wireless charging signal is detected by the user-wearable infusion pump when the second input is received.
33. The user-wearable infusion pump of claim 32, wherein the pump includes only a single input button.
34. The user-wearable infusion pump of claim 32, wherein the pump does not include a display screen.
35. The user-wearable infusion pump of claim 34, wherein the processor is further configured to wirelessly communicate pump information to a separate device for display on the separate device.
36. The user-wearable infusion pump of claim 32, further comprising an indicator light.
37. The user-wearable infusion pump of claim 36, wherein the indicator light is functionally linked to the input button such that the indicator light illuminates to indicate that input has been received via the input button.
38. The user-wearable infusion pump of claim 37, wherein the indicator light is functionally linked to the input button such that the indicator light illuminates to indicate when the first function is being executed and when the second function is being executed.
39. The user-wearable infusion pump of claim 38, wherein the indicator light is illuminated differently to indicate when the first function is being executed and when the second function is being executed.
40. The user-wearable infusion pump of claim 32, wherein the wireless charging signal is an inductive charging signal.
41. The user-wearable infusion pump of claim 32, wherein the first function is selected from the set consisting of initiating a medicament delivery operation with the user-wearable pump, communicatively coupling the pump with a remote control device, communicatively coupling the pump to a remote glucose monitor and initiating a status check of the user-wearable infusion pump.
42. The user-wearable infusion pump of claim 32, where the second function is selected from the set consisting of suspending delivery of the medicament with the user-wearable infusion pump, initiating a low-power shelf mode for the user-wearable infusion pump, resetting the processor of the user-wearable infusion pump, communicatively coupling the pump with a remote control device, communicatively coupling the pump to a remote glucose monitor, initiating a test routine of the user-wearable infusion pump and initiating a software update protocol.
US16/502,196 2017-01-11 2019-07-03 Electromagnetic signal-based infusion pump control Pending US20190321546A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/502,196 US20190321546A1 (en) 2017-01-11 2019-07-03 Electromagnetic signal-based infusion pump control

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762445041P 2017-01-11 2017-01-11
US15/868,461 US10357603B2 (en) 2017-01-11 2018-01-11 Electromagnetic signal-based infusion pump control
US16/502,196 US20190321546A1 (en) 2017-01-11 2019-07-03 Electromagnetic signal-based infusion pump control

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US15/868,461 Continuation US10357603B2 (en) 2017-01-11 2018-01-11 Electromagnetic signal-based infusion pump control

Publications (1)

Publication Number Publication Date
US20190321546A1 true US20190321546A1 (en) 2019-10-24

Family

ID=62782017

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/868,461 Active US10357603B2 (en) 2017-01-11 2018-01-11 Electromagnetic signal-based infusion pump control
US16/502,196 Pending US20190321546A1 (en) 2017-01-11 2019-07-03 Electromagnetic signal-based infusion pump control

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US15/868,461 Active US10357603B2 (en) 2017-01-11 2018-01-11 Electromagnetic signal-based infusion pump control

Country Status (3)

Country Link
US (2) US10357603B2 (en)
EP (1) EP3568174A4 (en)
WO (1) WO2018132578A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11147916B2 (en) 2015-08-20 2021-10-19 Tandem Diabetes Care, Inc. Drive mechanism for infusion pump
US11305057B2 (en) 2019-03-26 2022-04-19 Tandem Diabetes Care, Inc. Method and system of operating an infusion pump with a remote control device
US11317944B2 (en) 2011-03-14 2022-05-03 Unomedical A/S Inserter system with transport protection
US11357912B2 (en) 2016-01-19 2022-06-14 Unomedical A/S Cannula and infusion devices
US11458292B2 (en) 2019-05-20 2022-10-04 Unomedical A/S Rotatable infusion device and methods thereof
US11458246B2 (en) 2018-02-05 2022-10-04 Tandem Diabetes Care, Inc. Methods and systems for detecting infusion pump conditions
US11464901B2 (en) 2019-02-19 2022-10-11 Tandem Diabetes Care, Inc. System and method of pairing an infusion pump with a remote control device
US11617827B2 (en) 2005-09-12 2023-04-04 Unomedical A/S Invisible needle
USD1010816S1 (en) 2021-12-03 2024-01-09 Tandem Diabetes Care, Inc. User-wearable holder for medical device

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133197B2 (en) 2008-05-02 2012-03-13 Smiths Medical Asd, Inc. Display for pump
WO2015100439A1 (en) 2013-12-26 2015-07-02 Tandem Diabetes Care, Inc. Integration of infusion pump with remote electronic device
US10279106B1 (en) 2014-05-08 2019-05-07 Tandem Diabetes Care, Inc. Insulin patch pump
WO2016187286A1 (en) 2015-05-18 2016-11-24 Tandem Diabetes Care, Inc. Patch pump cartridge attachment
CN110520931A (en) * 2017-03-15 2019-11-29 诺瓦提斯公司 For by the system of drug products for administration
US11355225B2 (en) * 2017-03-15 2022-06-07 Novartis Ag System for use of a pharmaceutical product
US20190009019A1 (en) 2017-07-07 2019-01-10 Neuroderm, Ltd. Device for subcutaneous delivery of fluid medicament
US20230123806A1 (en) 2017-07-07 2023-04-20 Neuroderm, Ltd. Device for subcutaneous delivery of fluid medicament
EP3776801A4 (en) 2018-04-10 2021-12-22 Tandem Diabetes Care, Inc. System and method for inductively charging a medical device
JP7203350B2 (en) * 2019-01-30 2023-01-13 パナソニックIpマネジメント株式会社 Information processing system and information processing method
US20200368430A1 (en) 2019-05-21 2020-11-26 Tandem Diabetes Care, Inc. System and method for incorporating exercise into closed-loop diabetes therapy
WO2023064342A1 (en) * 2021-10-12 2023-04-20 Tandem Diabetes Care, Inc. Systems and method of pairing an infusion pump with a remote control device

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130042865A1 (en) * 2011-08-16 2013-02-21 Ploom, Inc. Low temperature electronic vaporization device and methods
US20130317837A1 (en) * 2012-05-24 2013-11-28 Deka Products Limited Partnership System, Method, and Apparatus for Electronic Patient Care
US20140175682A1 (en) * 2011-06-24 2014-06-26 Reckitt & Colman (Overseas) Limited Devices and Methods for Improved Delivery of Volatile Liquids
US20170179749A1 (en) * 2015-12-16 2017-06-22 Intel Corporation Device control for wireless charging
US20170173261A1 (en) * 2015-11-24 2017-06-22 Jason O'Connor Wearable automated medication delivery system

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582593A (en) 1994-07-21 1996-12-10 Hultman; Barry W. Ambulatory medication delivery system
US5860957A (en) 1997-02-07 1999-01-19 Sarcos, Inc. Multipathway electronically-controlled drug delivery system
US6001067A (en) 1997-03-04 1999-12-14 Shults; Mark C. Device and method for determining analyte levels
US7885697B2 (en) 2004-07-13 2011-02-08 Dexcom, Inc. Transcutaneous analyte sensor
US6070761A (en) 1997-08-22 2000-06-06 Deka Products Limited Partnership Vial loading method and apparatus for intelligent admixture and delivery of intravenous drugs
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6402689B1 (en) 1998-09-30 2002-06-11 Sicel Technologies, Inc. Methods, systems, and associated implantable devices for dynamic monitoring of physiological and biological properties of tumors
US7193521B2 (en) * 1998-10-29 2007-03-20 Medtronic Minimed, Inc. Method and apparatus for detecting errors, fluid pressure, and occlusions in an ambulatory infusion pump
US6561978B1 (en) 1999-02-12 2003-05-13 Cygnus, Inc. Devices and methods for frequent measurement of an analyte present in a biological system
US6514689B2 (en) 1999-05-11 2003-02-04 M-Biotech, Inc. Hydrogel biosensor
US7181505B2 (en) 1999-07-07 2007-02-20 Medtronic, Inc. System and method for remote programming of an implantable medical device
US7933780B2 (en) 1999-10-22 2011-04-26 Telaric, Llc Method and apparatus for controlling an infusion pump or the like
US7483743B2 (en) 2000-01-11 2009-01-27 Cedars-Sinai Medical Center System for detecting, diagnosing, and treating cardiovascular disease
US6873268B2 (en) 2000-01-21 2005-03-29 Medtronic Minimed, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US6713298B2 (en) 2000-01-31 2004-03-30 Board Of Regents, The University Of Texas System Method and apparatus for the delivery of samples to a chemical sensor array
WO2001088534A2 (en) 2000-05-16 2001-11-22 Cygnus, Inc. Methods for improving performance and reliability of biosensors
US7198603B2 (en) 2003-04-14 2007-04-03 Remon Medical Technologies, Inc. Apparatus and methods using acoustic telemetry for intrabody communications
WO2002066910A1 (en) * 2001-02-21 2002-08-29 Mitsubishi Chemical Corporation Adsorption heat pump, and use of adsorption material as adsorption material for adsorption heat pump
WO2003000127A2 (en) 2001-06-22 2003-01-03 Cygnus, Inc. Method for improving the performance of an analyte monitoring system
US6656159B2 (en) 2002-04-23 2003-12-02 Insulet Corporation Dispenser for patient infusion device
US6960192B1 (en) 2002-04-23 2005-11-01 Insulet Corporation Transcutaneous fluid delivery system
US8234128B2 (en) 2002-04-30 2012-07-31 Baxter International, Inc. System and method for verifying medical device operational parameters
US20040010207A1 (en) 2002-07-15 2004-01-15 Flaherty J. Christopher Self-contained, automatic transcutaneous physiologic sensing system
US7144384B2 (en) 2002-09-30 2006-12-05 Insulet Corporation Dispenser components and methods for patient infusion device
US7399401B2 (en) 2002-10-09 2008-07-15 Abbott Diabetes Care, Inc. Methods for use in assessing a flow condition of a fluid
WO2005007223A2 (en) 2003-07-16 2005-01-27 Sasha John Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
EP1646332B1 (en) 2003-07-18 2015-06-17 Edwards Lifesciences AG Remotely activated mitral annuloplasty system
US7651596B2 (en) 2005-04-08 2010-01-26 Dexcom, Inc. Cellulosic-based interference domain for an analyte sensor
US8369919B2 (en) 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US9135402B2 (en) 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20050075696A1 (en) * 2003-10-02 2005-04-07 Medtronic, Inc. Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device
US8774886B2 (en) 2006-10-04 2014-07-08 Dexcom, Inc. Analyte sensor
AU2004300168A1 (en) 2003-12-11 2005-06-30 Board Of Regents, The University Of Texas System Method and system for the analysis of saliva using a sensor array
WO2006097453A1 (en) * 2005-03-17 2006-09-21 Novo Nordisk A/S Securing pairing of electronic devices
WO2006105146A2 (en) 2005-03-29 2006-10-05 Arkal Medical, Inc. Devices, systems, methods and tools for continuous glucose monitoring
US7366925B2 (en) 2005-06-09 2008-04-29 Microsoft Corporation Portable power management for a computing device carrying case
US7737581B2 (en) 2005-08-16 2010-06-15 Medtronic Minimed, Inc. Method and apparatus for predicting end of battery life
US7813801B2 (en) 2005-12-15 2010-10-12 Cardiac Pacemakers, Inc. Implantable medical device powered by rechargeable battery
CN101401313B (en) * 2006-03-13 2014-06-11 诺沃—诺迪斯克有限公司 Secure pairing of electronic devices using dual means of communication
US7558629B2 (en) 2006-04-28 2009-07-07 Medtronic, Inc. Energy balance therapy for obesity management
US7539533B2 (en) 2006-05-16 2009-05-26 Bao Tran Mesh network monitoring appliance
US7605710B2 (en) 2006-08-18 2009-10-20 Fresenius Medical Care Holdings, Inc. Wetness sensor
US20080097913A1 (en) 2006-10-24 2008-04-24 Kent Dicks Systems and methods for wireless processing and transmittal of data from a plurality of medical devices
WO2008051939A2 (en) 2006-10-24 2008-05-02 Medapps, Inc. Systems and methods for medical data transmission
US20080097917A1 (en) 2006-10-24 2008-04-24 Kent Dicks Systems and methods for wireless processing and medical device monitoring via remote command execution
US20080097914A1 (en) 2006-10-24 2008-04-24 Kent Dicks Systems and methods for wireless processing and transmittal of medical data through multiple interfaces
US20080097912A1 (en) 2006-10-24 2008-04-24 Kent Dicks Systems and methods for wireless processing and transmittal of medical data through an intermediary device
US20080125700A1 (en) 2006-11-29 2008-05-29 Moberg Sheldon B Methods and apparatuses for detecting medical device acceleration, temperature, and humidity conditions
US7704227B2 (en) 2006-11-29 2010-04-27 Medtronic Minimed, Inc. Methods and apparatuses for detecting medical device acceleration, temperature, and humidity conditions
CN105327418B (en) 2006-12-22 2022-04-26 F·霍夫曼-拉罗氏股份公司 System and device for sustained delivery of therapeutic fluid
US7385443B1 (en) 2007-01-31 2008-06-10 Medtronic, Inc. Chopper-stabilized instrumentation amplifier
US20080231226A1 (en) 2007-03-23 2008-09-25 Eveready Battery Company, Inc. Battery Powered Device
US8034019B2 (en) 2007-04-10 2011-10-11 Amrita Vishwa Vidyapeetham Dual microcontroller-based liquid infusion system
US8444595B2 (en) 2007-06-15 2013-05-21 Animas Corporation Methods to pair a medical device and at least a remote controller for such medical device
US8449523B2 (en) 2007-06-15 2013-05-28 Animas Corporation Method of operating a medical device and at least a remote controller for such medical device
EP2183006B1 (en) 2007-07-20 2019-02-13 Roche Diabetes Care GmbH Manually operable portable infusion device
CN101808680B (en) 2007-08-01 2014-07-02 F·霍夫曼-拉罗氏股份公司 Portable infusion device provided with means for monitoring and controlling fluid delivery
US7714757B2 (en) 2007-09-26 2010-05-11 Medtronic, Inc. Chopper-stabilized analog-to-digital converter
US20090177142A1 (en) 2008-01-09 2009-07-09 Smiths Medical Md, Inc Insulin pump with add-on modules
US20090209945A1 (en) * 2008-01-18 2009-08-20 Neurosystec Corporation Valveless impedance pump drug delivery systems
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
CA2715628A1 (en) 2008-02-21 2009-08-27 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
MX2010010858A (en) * 2008-04-01 2010-11-01 Deka Products Lp Methods and systems for controlling an infusion pump.
US8655340B2 (en) * 2008-10-14 2014-02-18 At&T Intellectual Property I, L.P. Method, apparatus, and computer program product for wireless customer services
WO2010055504A1 (en) 2008-11-11 2010-05-20 Medingo Ltd. Modular fluid delivery device with quick-release /connect mechanism for drive screw
CN201319516Y (en) 2008-11-26 2009-09-30 广州西格美信电子科技有限公司 Self-adapting external battery for mobile devices
US20100198142A1 (en) 2009-02-04 2010-08-05 Abbott Diabetes Care Inc. Multi-Function Analyte Test Device and Methods Therefor
US8573027B2 (en) 2009-02-27 2013-11-05 Tandem Diabetes Care, Inc. Methods and devices for determination of flow reservoir volume
US9687194B2 (en) 2009-06-17 2017-06-27 Medtronic Minimed, Inc. Closed-loop glucose and/or insulin control system
CA2921304C (en) * 2009-07-30 2018-06-05 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US9744365B2 (en) 2010-01-08 2017-08-29 Medtronic, Inc. Presentation of information associated with medical device therapy
US10453157B2 (en) 2010-01-22 2019-10-22 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US10195343B2 (en) * 2010-02-05 2019-02-05 Deka Products Limited Partnership Devices, methods and systems for wireless control of medical devices
US8454554B2 (en) * 2010-10-15 2013-06-04 Roche Diagnostics Operations, Inc. Use of a handheld medical device as a communications mediator between a personal computer-based configurator and another networked medical device
US8639288B1 (en) * 2011-02-22 2014-01-28 Medavie Technologies Injector device
WO2012122520A1 (en) 2011-03-10 2012-09-13 Abbott Diabetes Care Inc. Multi-function analyte monitor device and methods of use
US20130053816A1 (en) 2011-07-25 2013-02-28 Tandem Diabetes Care, Inc. Multi-reservoir infusion pump systems and methods
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US9381297B2 (en) 2012-06-07 2016-07-05 Tandem Diabetes Care, Inc. Sealed infusion device with electrical connector port
US8454557B1 (en) 2012-07-19 2013-06-04 Asante Solutions, Inc. Infusion pump system and method
US20140276423A1 (en) 2013-03-14 2014-09-18 Tandem Diabetes Care, Inc. Infusion system and methods
US9155900B2 (en) * 2013-06-20 2015-10-13 Cochlear Limited Medical device battery charging system and methods
US20170216523A1 (en) * 2014-10-17 2017-08-03 Debiotech S.A. Secure Bolus-Control System
MX2017011557A (en) * 2015-03-09 2018-04-10 Amgen Inc Drive mechanisms for drug delivery pumps.
WO2016187286A1 (en) 2015-05-18 2016-11-24 Tandem Diabetes Care, Inc. Patch pump cartridge attachment
WO2017031407A1 (en) 2015-08-20 2017-02-23 Tandem Diabetes Care, Inc. Drive mechanism for infusion pump
US10492141B2 (en) 2015-11-17 2019-11-26 Tandem Diabetes Care, Inc. Methods for reduction of battery usage in ambulatory infusion pumps
US10926025B2 (en) 2016-09-15 2021-02-23 Tandem Diabetes Care, Inc. Vial supporter for medicament pump

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140175682A1 (en) * 2011-06-24 2014-06-26 Reckitt & Colman (Overseas) Limited Devices and Methods for Improved Delivery of Volatile Liquids
US20130042865A1 (en) * 2011-08-16 2013-02-21 Ploom, Inc. Low temperature electronic vaporization device and methods
US20130317837A1 (en) * 2012-05-24 2013-11-28 Deka Products Limited Partnership System, Method, and Apparatus for Electronic Patient Care
US20170173261A1 (en) * 2015-11-24 2017-06-22 Jason O'Connor Wearable automated medication delivery system
US20170179749A1 (en) * 2015-12-16 2017-06-22 Intel Corporation Device control for wireless charging

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11617827B2 (en) 2005-09-12 2023-04-04 Unomedical A/S Invisible needle
US11317944B2 (en) 2011-03-14 2022-05-03 Unomedical A/S Inserter system with transport protection
US11147916B2 (en) 2015-08-20 2021-10-19 Tandem Diabetes Care, Inc. Drive mechanism for infusion pump
US11357912B2 (en) 2016-01-19 2022-06-14 Unomedical A/S Cannula and infusion devices
US11458246B2 (en) 2018-02-05 2022-10-04 Tandem Diabetes Care, Inc. Methods and systems for detecting infusion pump conditions
US11464901B2 (en) 2019-02-19 2022-10-11 Tandem Diabetes Care, Inc. System and method of pairing an infusion pump with a remote control device
US11305057B2 (en) 2019-03-26 2022-04-19 Tandem Diabetes Care, Inc. Method and system of operating an infusion pump with a remote control device
US11458292B2 (en) 2019-05-20 2022-10-04 Unomedical A/S Rotatable infusion device and methods thereof
US11944775B2 (en) 2019-05-20 2024-04-02 Unomedical A/S Rotatable infusion device and methods thereof
USD1010816S1 (en) 2021-12-03 2024-01-09 Tandem Diabetes Care, Inc. User-wearable holder for medical device

Also Published As

Publication number Publication date
US20180193555A1 (en) 2018-07-12
EP3568174A4 (en) 2020-07-29
US10357603B2 (en) 2019-07-23
WO2018132578A1 (en) 2018-07-19
EP3568174A1 (en) 2019-11-20

Similar Documents

Publication Publication Date Title
US10357603B2 (en) Electromagnetic signal-based infusion pump control
US11305057B2 (en) Method and system of operating an infusion pump with a remote control device
US11464901B2 (en) System and method of pairing an infusion pump with a remote control device
US20210162117A1 (en) Patch pump cartridge attachment
US11838867B2 (en) Methods for reduction of battery usage in ambulatory infusion pumps
US20200114076A1 (en) System and method for switching between medicament delivery control algorithms
CN101401313B (en) Secure pairing of electronic devices using dual means of communication
EP2033068B1 (en) Method and apparatus for providing power to a portable electronic device
CN111446980B (en) Systems, apparatuses, and methods for enhanced notification to a user of a wearable medical device
US11109316B2 (en) Methods of wireless communication in an infusion pump system
US20090062778A1 (en) Medical System Comprising Dual-Purpose Communication Means
US20200206420A1 (en) Methods of wireless communication in an infusion pump system
JP2023162384A (en) Medical device, method and system
US20200372995A1 (en) Systems and methods of pairing devices in an ambulatory infusion pump system
CN110506426B (en) Method of pairing two devices for wireless communication therebetween
US20230166033A1 (en) Bolus permissions and prioritization scheme for infusion pump system
WO2023064342A1 (en) Systems and method of pairing an infusion pump with a remote control device

Legal Events

Date Code Title Description
AS Assignment

Owner name: TANDEM DIABETES CARE, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MICHAUD, MICHAEL;BROWN, JUSTIN;BUTLER, CALEB;SIGNING DATES FROM 20180116 TO 20180430;REEL/FRAME:049661/0012

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

AS Assignment

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, CALIFORNIA

Free format text: SECURITY INTEREST;ASSIGNOR:TANDEM DIABETES CARE, INC.;REEL/FRAME:060179/0100

Effective date: 20220518

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

AS Assignment

Owner name: TANDEM DIABETES CARE, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:066880/0918

Effective date: 20240319